Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers

We began analyzing https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06523-1, but it redirected us to https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06523-1. The analysis below is for the second page.

Title[redir]:
Preliminary exploration of PSMA CAR-T combined with GD2 CAR-T for the treatment of refractory/relapsed gliomas | Journal of Translational Medicine | Full Text
Description:
Background This study aimed to investigate the safety and efficacy of fourth-generation combined PSMA and GD2-targeted chimeric antigen receptor (CAR)-T cells in the treatment of refractory/relapsed gliomas. Method This study employed a single-arm design, enrolling patients with confirmed refractory/relapsed gliomas at the Immuno-oncology Department of the Cancer Center at Clifford Hospital in Guangdong. Eligible patients received combined treatment with PSMA CAR-T and GD2 CAR-T cells via intravenous administration. The dose of reinfused CAR-T cells ranged from 1–5 × 10^6 cells/kg of body weight. Results Six patients were included in the study, all of whom responded to the treatment. The overall response rate (ORR) was 50%, with three patients achieving complete response (CR) (50%) and three demonstrating stable disease (SD) (50%). The median progression-free survival (PFS) was 9.0 months (range, 1–56 months), and the median overall survival (OS) was 24.5 months (range, 13–63 months). Three patients (50%) developed cytokine release syndrome (CRS), all of which were classified as grade I CRS, and no patients experienced immune effector cell-associated neurotoxicity Syndrome (ICANS). Conclusion Combined PSMA CAR-T and GD2 CAR-T cell therapy demonstrated significant efficacy and good tolerability in the treatment of refractory/relapsed gliomas, without severe adverse reactions.

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🚀 Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 50,420 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't see how the site brings in money.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cart, patients, pubmed, article, cells, google, scholar, therapy, psma, tumor, months, patient, cell, treatment, gliomas, central, infusion, cas, study, fig, survival, clinical, car, glioblastoma, table, efficacy, median, cancer, refractory, pfs, relapsed, outcomes, blood, antigen, safety, trial, size, response, disease, tumors, lymphoma, glioma, med, oncol, grade, brain, diffuse, additional, data, adverse,

Topics {✒️}

chimeric antigen receptor-modified dual-targeted fourth-generation car gd2-car t-cells display fourth-generation safety-designed car population-based case-control study prostate-specific membrane antigen dual-target antigen cars b-cell lymphoblastic leukemia chimeric antigen receptor dual igf1r/ir inhibitors sun yat-sen university intrinsic interleukin-15rα signaling o6-methylguanine-dna methyltransferase central nervous system car t-cell therapy chronic/acute lymphocytic leukemia kaplan–meier survival analysis 68ga-psma-hbed-cc refractory mantle-cell lymphoma underwent tumor-treating fields potent anti-tumor activity immune-compromised leukemic patient targeting gd2-positive glioblastoma blood–brain barrier facilitates intraventricular b7–h3 car subsequent long-term follow il-13rα2-targeting car refractory high-risk neuroblastoma fourth-generation combined psma received tumor-treating fields single-arm trial design high-risk glioma treated recent meta-analysis reported dual-targeting strategy privacy choices/manage cookies autologous anti-gd2 car time points post-car recurrent high-grade glioma lung-ji chang van den bent multiple time points bmc median progression-free survival pfs progression-free survival authors scientific editing complete remission rates state privacy rights haijun wen schuster sj dual-target strategy

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Preliminary exploration of PSMA CAR-T combined with GD2 CAR-T for the treatment of refractory/relapsed gliomas
         description:This study aimed to investigate the safety and efficacy of fourth-generation combined PSMA and GD2-targeted chimeric antigen receptor (CAR)-T cells in the treatment of refractory/relapsed gliomas. This study employed a single-arm design, enrolling patients with confirmed refractory/relapsed gliomas at the Immuno-oncology Department of the Cancer Center at Clifford Hospital in Guangdong. Eligible patients received combined treatment with PSMA CAR-T and GD2 CAR-T cells via intravenous administration. The dose of reinfused CAR-T cells ranged from 1–5 × 10^6 cells/kg of body weight. Six patients were included in the study, all of whom responded to the treatment. The overall response rate (ORR) was 50%, with three patients achieving complete response (CR) (50%) and three demonstrating stable disease (SD) (50%). The median progression-free survival (PFS) was 9.0 months (range, 1–56 months), and the median overall survival (OS) was 24.5 months (range, 13–63 months). Three patients (50%) developed cytokine release syndrome (CRS), all of which were classified as grade I CRS, and no patients experienced immune effector cell-associated neurotoxicity Syndrome (ICANS). Combined PSMA CAR-T and GD2 CAR-T cell therapy demonstrated significant efficacy and good tolerability in the treatment of refractory/relapsed gliomas, without severe adverse reactions.
         datePublished:2025-05-27T00:00:00Z
         dateModified:2025-06-21T00:00:00Z
         pageStart:1
         pageEnd:13
         license:http://creativecommons.org/licenses/by-nc-nd/4.0/
         sameAs:https://doi.org/10.1186/s12967-025-06523-1
         keywords:
            Refractory/relapsed gliomas
            PSMA CAR-T therapy
            GD2 CAR-T therapy
            Combination therapy
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-025-06523-1/MediaObjects/12967_2025_6523_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-025-06523-1/MediaObjects/12967_2025_6523_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-025-06523-1/MediaObjects/12967_2025_6523_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-025-06523-1/MediaObjects/12967_2025_6523_Fig4_HTML.png
         isPartOf:
            name:Journal of Translational Medicine
            issn:
               1479-5876
            volumeNumber:23
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jinshan Gu
               affiliation:
                     name:Guangdong Clifford Hospital
                     address:
                        name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jiasheng Li
               url:http://orcid.org/0000-0002-3378-3123
               affiliation:
                     name:Sun Yat-Sen University
                     address:
                        name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yang Xu
               affiliation:
                     name:Sun Yat-Sen University
                     address:
                        name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ge Zhang
               affiliation:
                     name:Guangdong Clifford Hospital
                     address:
                        name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jingyi Xie
               affiliation:
                     name:Guangdong Clifford Hospital
                     address:
                        name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rui Jia
               affiliation:
                     name:Guangdong Clifford Hospital
                     address:
                        name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wei Chen
               affiliation:
                     name:Guangdong Clifford Hospital
                     address:
                        name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhengfeng Lu
               affiliation:
                     name:Guangdong Clifford Hospital
                     address:
                        name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chengwei Chang
               affiliation:
                     name:Shenzhen Geno-Immune Medical Institute
                     address:
                        name:Shenzhen Geno-Immune Medical Institute, Shenzhen, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Haijun Wen
               affiliation:
                     name:Sun Yat-Sen University
                     address:
                        name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lung-ji Chang
               affiliation:
                     name:Shenzhen Geno-Immune Medical Institute
                     address:
                        name:Shenzhen Geno-Immune Medical Institute, Shenzhen, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Huajuan Ma
               affiliation:
                     name:Guangdong Clifford Hospital
                     address:
                        name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Qichun Cai
               affiliation:
                     name:Guangdong Clifford Hospital
                     address:
                        name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Preliminary exploration of PSMA CAR-T combined with GD2 CAR-T for the treatment of refractory/relapsed gliomas
      description:This study aimed to investigate the safety and efficacy of fourth-generation combined PSMA and GD2-targeted chimeric antigen receptor (CAR)-T cells in the treatment of refractory/relapsed gliomas. This study employed a single-arm design, enrolling patients with confirmed refractory/relapsed gliomas at the Immuno-oncology Department of the Cancer Center at Clifford Hospital in Guangdong. Eligible patients received combined treatment with PSMA CAR-T and GD2 CAR-T cells via intravenous administration. The dose of reinfused CAR-T cells ranged from 1–5 × 10^6 cells/kg of body weight. Six patients were included in the study, all of whom responded to the treatment. The overall response rate (ORR) was 50%, with three patients achieving complete response (CR) (50%) and three demonstrating stable disease (SD) (50%). The median progression-free survival (PFS) was 9.0 months (range, 1–56 months), and the median overall survival (OS) was 24.5 months (range, 13–63 months). Three patients (50%) developed cytokine release syndrome (CRS), all of which were classified as grade I CRS, and no patients experienced immune effector cell-associated neurotoxicity Syndrome (ICANS). Combined PSMA CAR-T and GD2 CAR-T cell therapy demonstrated significant efficacy and good tolerability in the treatment of refractory/relapsed gliomas, without severe adverse reactions.
      datePublished:2025-05-27T00:00:00Z
      dateModified:2025-06-21T00:00:00Z
      pageStart:1
      pageEnd:13
      license:http://creativecommons.org/licenses/by-nc-nd/4.0/
      sameAs:https://doi.org/10.1186/s12967-025-06523-1
      keywords:
         Refractory/relapsed gliomas
         PSMA CAR-T therapy
         GD2 CAR-T therapy
         Combination therapy
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-025-06523-1/MediaObjects/12967_2025_6523_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-025-06523-1/MediaObjects/12967_2025_6523_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-025-06523-1/MediaObjects/12967_2025_6523_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-025-06523-1/MediaObjects/12967_2025_6523_Fig4_HTML.png
      isPartOf:
         name:Journal of Translational Medicine
         issn:
            1479-5876
         volumeNumber:23
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jinshan Gu
            affiliation:
                  name:Guangdong Clifford Hospital
                  address:
                     name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jiasheng Li
            url:http://orcid.org/0000-0002-3378-3123
            affiliation:
                  name:Sun Yat-Sen University
                  address:
                     name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yang Xu
            affiliation:
                  name:Sun Yat-Sen University
                  address:
                     name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ge Zhang
            affiliation:
                  name:Guangdong Clifford Hospital
                  address:
                     name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jingyi Xie
            affiliation:
                  name:Guangdong Clifford Hospital
                  address:
                     name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rui Jia
            affiliation:
                  name:Guangdong Clifford Hospital
                  address:
                     name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wei Chen
            affiliation:
                  name:Guangdong Clifford Hospital
                  address:
                     name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhengfeng Lu
            affiliation:
                  name:Guangdong Clifford Hospital
                  address:
                     name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chengwei Chang
            affiliation:
                  name:Shenzhen Geno-Immune Medical Institute
                  address:
                     name:Shenzhen Geno-Immune Medical Institute, Shenzhen, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Haijun Wen
            affiliation:
                  name:Sun Yat-Sen University
                  address:
                     name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lung-ji Chang
            affiliation:
                  name:Shenzhen Geno-Immune Medical Institute
                  address:
                     name:Shenzhen Geno-Immune Medical Institute, Shenzhen, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Huajuan Ma
            affiliation:
                  name:Guangdong Clifford Hospital
                  address:
                     name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Qichun Cai
            affiliation:
                  name:Guangdong Clifford Hospital
                  address:
                     name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Translational Medicine
      issn:
         1479-5876
      volumeNumber:23
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Guangdong Clifford Hospital
      address:
         name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
         type:PostalAddress
      name:Sun Yat-Sen University
      address:
         name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
         type:PostalAddress
      name:Sun Yat-Sen University
      address:
         name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
         type:PostalAddress
      name:Guangdong Clifford Hospital
      address:
         name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
         type:PostalAddress
      name:Guangdong Clifford Hospital
      address:
         name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
         type:PostalAddress
      name:Guangdong Clifford Hospital
      address:
         name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
         type:PostalAddress
      name:Guangdong Clifford Hospital
      address:
         name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
         type:PostalAddress
      name:Guangdong Clifford Hospital
      address:
         name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
         type:PostalAddress
      name:Shenzhen Geno-Immune Medical Institute
      address:
         name:Shenzhen Geno-Immune Medical Institute, Shenzhen, China
         type:PostalAddress
      name:Sun Yat-Sen University
      address:
         name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
         type:PostalAddress
      name:Shenzhen Geno-Immune Medical Institute
      address:
         name:Shenzhen Geno-Immune Medical Institute, Shenzhen, China
         type:PostalAddress
      name:Guangdong Clifford Hospital
      address:
         name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
         type:PostalAddress
      name:Guangdong Clifford Hospital
      address:
         name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jinshan Gu
      affiliation:
            name:Guangdong Clifford Hospital
            address:
               name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Jiasheng Li
      url:http://orcid.org/0000-0002-3378-3123
      affiliation:
            name:Sun Yat-Sen University
            address:
               name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Yang Xu
      affiliation:
            name:Sun Yat-Sen University
            address:
               name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Ge Zhang
      affiliation:
            name:Guangdong Clifford Hospital
            address:
               name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Jingyi Xie
      affiliation:
            name:Guangdong Clifford Hospital
            address:
               name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Rui Jia
      affiliation:
            name:Guangdong Clifford Hospital
            address:
               name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Wei Chen
      affiliation:
            name:Guangdong Clifford Hospital
            address:
               name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Zhengfeng Lu
      affiliation:
            name:Guangdong Clifford Hospital
            address:
               name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Chengwei Chang
      affiliation:
            name:Shenzhen Geno-Immune Medical Institute
            address:
               name:Shenzhen Geno-Immune Medical Institute, Shenzhen, China
               type:PostalAddress
            type:Organization
      name:Haijun Wen
      affiliation:
            name:Sun Yat-Sen University
            address:
               name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
               type:PostalAddress
            type:Organization
      name:Lung-ji Chang
      affiliation:
            name:Shenzhen Geno-Immune Medical Institute
            address:
               name:Shenzhen Geno-Immune Medical Institute, Shenzhen, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Huajuan Ma
      affiliation:
            name:Guangdong Clifford Hospital
            address:
               name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Qichun Cai
      affiliation:
            name:Guangdong Clifford Hospital
            address:
               name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
      name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
      name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
      name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
      name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
      name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
      name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
      name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
      name:Shenzhen Geno-Immune Medical Institute, Shenzhen, China
      name:State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China
      name:Shenzhen Geno-Immune Medical Institute, Shenzhen, China
      name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China
      name:Immuno-oncology department of the cancer center, 21 st Floor, Building 2, Guangdong Clifford Hospital, Guangzhou, China

External Links {🔗}(338)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
3.52s.